CytoDyn Inc. Research And Development Expense

• CytoDyn Inc. showed an increase of +175.1% in Research And Development Expense from 2023 to 2024.
• This data is from CytoDyn Inc.'s annual report (Form 10-K), filed with the SEC on August 15, 2024.
• XBRL data for this metric is available from 2011 to 2024 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 14 years of available data (2011 to 2024), CytoDyn Inc.'s Research And Development Expense has grown by 1,405.9%.
• Historical annual values: Fiscal year 2024: $7.24 million | Fiscal year 2023: $2.63 million | Fiscal year 2022: $27.04 million | Fiscal year 2021: $53.40 million | Fiscal year 2020: $52.64 million | Fiscal year 2019: $42.49 million | Fiscal year 2018: $38.22 million | Fiscal year 2017: $20.21 million | Fiscal year 2016: $13.73 million | Fiscal year 2015: $15.16 million | Fiscal year 2014: $3.98 million | Fiscal year 2013: $619.8 thousand | Fiscal year 2012: $530.0 thousand | Fiscal year 2011: $480.8 thousand.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026